Hygieia insulin management specialists add world-renowned endocrinologist George Grunberger, M.D., to advisory board | Hygieia

Hygieia insulin management specialists add world-renowned endocrinologist George Grunberger, M.D., to advisory board

Livonia, Mich., October 19, 2020Hygieia, a Livonia-based specialty provider of insulin management, is adding internationally preeminent endocrinologist Dr. George Grunberger to its advisory board, effective October 1, 2020.

Grunberger, head of the Grunberger Diabetes Institute in Bloomfield Hills, Mich., is a past president of the American Association of Clinical Endocrinologists, Master of the American College of Endocrinology, and an extensively published author, speaker and clinical researcher specializing in comprehensive diabetes care. He has been named one of the Best Doctors in America® every year since 2001.

“George brings decades of clinical expertise in diabetes management to help guide Hygieia to best meet patient needs,” said Eran Bashan, Ph.D., CEO of Hygieia. “Our revolutionary program will continue to evolve and improve with his insight. We’re thrilled to have him join our advisory board.”

Hygieia’s unique d-Nav® Insulin Management Program combines virtual clinical support with an AI-powered app that prescribes the appropriate insulin dose each time a patient prepares to inject. The result is safe and effective insulin treatment that has nearly 90 percent of patients seeing improved A1c levels within 90 days.

“I’ve been testing Hygieia’s d-Nav program with my patients since 2016, and the results have been outstanding. Now, I will be incorporating the d-Nav program into a standard protocol for eligible patients in my practice,” said Dr. Grunberger. “As a Hygieia advisory board member, I will bring the user perspective to the table and advise on future development.”

The current standard of insulin therapy gives patients limited ability to modify their insulin prescription until they see their doctor for dose adjustments. But the body’s insulin needs are dynamic and often require more frequent titration. With the d-Nav program, the insulin dose can be adjusted more frequently, so people get more appropriate doses to meet their needs.

For more information on Hygieia’s d-Nav Insulin Management System, visit hygieia.com or call 734-369-9980.

About Hygieia/ d-Nav Insulin Management System
Hygieia is a specialty provider of insulin therapy and maker of the d-Nav® Insulin Management Program. The d-Nav program includes an AI-powered application that helps people with Type 2 diabetes use insulin in a safe and effective way to control their blood sugar levels. Studies show that some 90 percent of people using d-Nav® achieve lower HbA1c within three months. The d-Nav® Insulin Management Program was developed by two University of Michigan researchers and has been peer-reviewed with studies published in leading medical journals. Hygieia is headquartered in Livonia, Michigan. Learn more at hygieia.com.